2-(3-fluoro-3'-methoxybiphenyl-4-carbamoyl)cyclopent-1-enecarboxylic acid,
4SC-101,
vidofludimus,
Vidofludimus,
717824-30-1,
4SC-101,
UNII-8Y1PJ3VG81,
SC12267,
SC 12267,
8Y1PJ3VG81,
CHEMBL197194,
2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic Acid,
Vidofludimus(4SC-101; SC12267),
2-[[2-fluoranyl-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid,
2-{[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl}cyclopent-1-ene-1-carboxylic acid,
Vidofludimus [INN],
SCHEMBL247888,
GTPL9860,
BDBM16111,
KS-00000TTT,
DTXSID50431325,
EX-A546,
AOB87354,
BCP14555,
s7262,
ZINC14960644,
AKOS026750557,
CS-3221,
SB19828,
NCGC00345056-01,
NCGC00345056-04,
AK547932,
BC600643,
DA-41592,
HY-14908,
Biphenyl-4-ylcarbamoyl Cyclopentene Analog 2,
FT-0700354,
2-(3-fluoro-3'-methoxybiphenyl-4-ylcarbamoyl)cyclopent-1-enecarboxylic acid,
2-(N-(3-Fluoro-3'-methoxy(1,1'-biphenyl)-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylic acid,
D5H,
D00LSI,
AL-082D06,
CID9820008,
B4669,
A12997,
2-[(3-fluoro-3'-methoxybiphenyl-4-yl)carbamoyl]cyclopent-1-ene-1-carboxylic acid,